Knight; Chris

Patent Applications and Registrations

Patent applications and USPTO patent grants for Knight; Chris.The latest application filed is for "vasopressin receptor antagonists and products and methods related thereto".

Company Profile

4.15.16

Knight; Chris - Saffron Walden GB
Knight; Chris - Ottawa CA
Knight; Chris - Little Chesterford Saffron Walden
KNIGHT; Chris - Charlotte NC
Knight; Chris - Essex N/A GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vasopressin receptor antagonists and products and methods related thereto Grant 11,186,577 - Jones , et al. November 30, 2	2021-11-30
Vasopressin Receptor Antagonists And Products And Methods Related Thereto App 20210317126 - Jones; Robert M. ; et al.	2021-10-14
An On-line System And Method For Searching Recipes For Meal Planning App 20210279294 - Knight; Chris	2021-09-09
Vasopressin receptor antagonists and products and methods related thereto Grant 10,538,530 - Jones , et al. Ja	2020-01-21
Vasopressin Receptor Antagonists And Products And Methods Related Thereto App 20190169202 - Jones; Robert M. ; et al.	2019-06-06
Vasopressin Receptor Antagonists And Products And Methods Related Thereto App 20190048013 - Jones; Robert M. ; et al.	2019-02-14
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 10,196,386 - Rancati , et al. Fe	2019-02-05
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Grant 10,004,728 - Rancati , et al. June 26, 2	2018-06-26
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20180016267 - RANCATI; Fabio ; et al.	2018-01-18
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 9,662,323 - Carzaniga , et al. May 30, 2	2017-05-30
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20170119753 - RANCATI; Fabio ; et al.	2017-05-04
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Grant 9,579,314 - Rancati , et al. February 28, 2	2017-02-28
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20160346271 - CARZANIGA; Laura ; et al.	2016-12-01
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 9,453,013 - Rancati , et al. September 27, 2	2016-09-27
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20160235734 - RANCATI; Fabio ; et al.	2016-08-18
Solar Canopy Assembly Tooling, Method of Assembling a Solar Canopy and a Solar Canopy App 20160190974 - DICKEY; Matthew ; et al.	2016-06-30
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20150139916 - RANCATI; Fabio ; et al.	2015-05-21
5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate(SIP)receptors Grant 9,029,405 - Bombrun , et al. May 12, 2	2015-05-12
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 9,012,644 - Rancati , et al. April 21, 2	2015-04-21
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 8,980,913 - Rancati , et al. March 17, 2	2015-03-17
Pyrazole oxadiazole derivatives as S1P.sub.1 agonists Grant 8,802,663 - Quattropani , et al. August 12, 2	2014-08-12
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20140163066 - RANCATI; Fabio ; et al.	2014-06-12
5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl Derivatives As Ligands On The Sphingosine 1-phosphate(sip)receptors App 20130116289 - Bombrun; Agnes ; et al.	2013-05-09
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20130034504 - RANCATI; Fabio ; et al.	2013-02-07
Triazole oxadiazoles derivatives Grant 8,202,856 - Quattropani , et al. June 19, 2	2012-06-19
Pyrazole Oxadiazole Derivatives As S1p1 Agonists App 20120071460 - Quattropani; Anna ; et al.	2012-03-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.